These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37748516)

  • 1. Post COVID-19 Large Vessel Vasculopathy in a Previously Healthy Young Male.
    Fan BE; Mucheli SS; Tang YL; Yong E; Dalan R; Cheung C; Young BE; Lye DCB; Wang L; Tan CW; Lim KHT; Sum CLL; Gallardo CA; Christopher D; Leung BP; Lim XR; Wong SW; Chia YW; Chong VCL;
    Semin Thromb Hemost; 2024 Jun; 50(4):660-663. PubMed ID: 37748516
    [No Abstract]   [Full Text] [Related]  

  • 2. Linking ACE2 and angiotensin II to pulmonary immunovascular dysregulation in SARS-CoV-2 infection.
    Seltzer S
    Int J Infect Dis; 2020 Dec; 101():42-45. PubMed ID: 32950735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasculopathy in COVID-19.
    Flaumenhaft R; Enjyoji K; Schmaier AA
    Blood; 2022 Jul; 140(3):222-235. PubMed ID: 34986238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous coronary artery dissection in a patient with COVID-19.
    Papanikolaou J; Alharthy A; Platogiannis N; Balhamar A; Alqahtani SA; Memish ZA; Karakitsos D
    Coron Artery Dis; 2021 Jun; 32(4):354-355. PubMed ID: 33394695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 lung disease is a pulmonary vasculopathy.
    Lloyd-Jones G; Alcock R; Oudkerk M
    Clin Radiol; 2024 Jul; 79(7):e975-e978. PubMed ID: 38714395
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19 Vasculopathy and Post-COVID-19 Phenomenon: Reply.
    Akgul A
    Ann Thorac Surg; 2021 May; 111(5):1735-1736. PubMed ID: 33875138
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaso-occlusive crisis in a patient with sickle cell trait and COVID-19.
    Freitas LAR; Carvalho LVS; Fontes JLM; Souza CS; Santos RB; Cardoso LT; Figueira CP; Fonseca Neto MS; Dias RCMF; Solcà MS; Gonçalves MS; Yahouedehou SCMA; Nunes CLX; Oliveira GGS; Dos-Santos WLC
    J Cell Mol Med; 2021 Nov; 25(21):10318-10320. PubMed ID: 34687139
    [No Abstract]   [Full Text] [Related]  

  • 8. A retrospective study on the prevalence of anti-phospholipid antibodies, thrombotic events and cutaneous signs of vasculopathy in 173 hospitalized COVID-19 patients.
    Gasparini G; Canepa P; Verdiani S; Carmisciano L; Cozzani E; De Grazia D; Andrea O; Icardi G; Parodi A
    Int J Immunopathol Pharmacol; 2021; 35():20587384211042115. PubMed ID: 34541915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From cellular function to global impact: the vascular perspective on COVID-19.
    Strauss SA; Seo C; Carrier M; Jetty P
    Can J Surg; 2021 May; 64(3):E289-E297. PubMed ID: 33978563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection?
    Mondal R; Lahiri D; Deb S; Bandyopadhyay D; Shome G; Sarkar S; Paria SR; Thakurta TG; Singla P; Biswas SC
    J Thromb Thrombolysis; 2020 Oct; 50(3):567-579. PubMed ID: 32627126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID Purpura (Toes) Case Series: A Chilblains-Like Vasculopathy.
    Olsen TG; Shrit MA; Feeser TA; Wargo JJ
    Am J Dermatopathol; 2021 Apr; 43(4):e47-e50. PubMed ID: 33156022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapidly progressive graft vasculopathy in a heart transplant recipient with confirmed SARS-CoV-2 infection.
    MacKay M; Clewis M; Khalife W
    Transpl Infect Dis; 2024 Feb; 26(1):e14225. PubMed ID: 38152037
    [No Abstract]   [Full Text] [Related]  

  • 13. Endothelial dysfunction in COVID-19: A potential predictor of long-COVID?
    Seitz A; Ong P
    Int J Cardiol; 2022 Feb; 349():155-156. PubMed ID: 34838682
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19 - A vascular disease.
    Siddiqi HK; Libby P; Ridker PM
    Trends Cardiovasc Med; 2021 Jan; 31(1):1-5. PubMed ID: 33068723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent endothelial dysfunction in post-COVID-19 syndrome and its associations with symptom severity and chronic inflammation.
    Kuchler T; Günthner R; Ribeiro A; Hausinger R; Streese L; Wöhnl A; Kesseler V; Negele J; Assali T; Carbajo-Lozoya J; Lech M; Schneider H; Adorjan K; Stubbe HC; Hanssen H; Kotilar K; Haller B; Heemann U; Schmaderer C
    Angiogenesis; 2023 Nov; 26(4):547-563. PubMed ID: 37507580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary livedoid vasculopathy following SARS-CoV-2 infection.
    Carballido Vázquez AM; Vega López TL; Manchado López P; Martínez García G; Mateos Mayo A
    J Eur Acad Dermatol Venereol; 2024 May; 38(5):e368-e370. PubMed ID: 38095220
    [No Abstract]   [Full Text] [Related]  

  • 17. Endothelial dysfunction contributes to COVID-19-associated vascular inflammation and coagulopathy.
    Zhang J; Tecson KM; McCullough PA
    Rev Cardiovasc Med; 2020 Sep; 21(3):315-319. PubMed ID: 33070537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purpuric dermatosis and lymphocytic vasculopathy following SARS-CoV-2 vaccination: Report of two patients.
    Saffarian Z; Samii R; Hadizadeh A; Ghanadan A; Vahidnezhad H
    Dermatol Ther; 2022 Nov; 35(11):e15898. PubMed ID: 36196579
    [No Abstract]   [Full Text] [Related]  

  • 19. SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients.
    Kumar A; Narayan RK; Kumari C; Faiq MA; Kulandhasamy M; Kant K; Pareek V
    Med Hypotheses; 2020 Dec; 145():110320. PubMed ID: 33032170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recrudescence of livedoid vasculopathy induced by COVID-19.
    Valentim FO; Tsutsui GM; Miot HA
    Int J Dermatol; 2021 May; 60(5):e185-e187. PubMed ID: 33527356
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.